OPG has been implicated as a potential mediator and biomarker in a variety of cardiovascular diseases, particularly cardiometabolic conditions (Pérez de Ciriza et al., 2015) and pulmonary hypertension (Lawrie et al., 2008, Condliffe et al., 2012). This evidence concerns the gene TNFRSF11B and pulmonary arterial hypertension.